Li Cai

Holistic Medicine
464 Commonwealth Ave
Apt. No. 16
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Compound EGFR Mutations Are Predominantly P-Loop and Alpha-C Helix Compressing Mutations With Increased Responsiveness to Second- Versus Third-Generation Tyrosine Kinase Inhibitors.

Compound EGFR Mutations Are Predominantly P-Loop and Alpha-C Helix Compressing Mutations With Increased Responsiveness to Second- Versus Third-Generation Tyrosine Kinase Inhibitors.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 21, 2025

Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model.

Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model.

Journal: Cancer discovery
Published: April 08, 2024

DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosis.

DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosis.

Journal: Nature communications
Published: February 29, 2024

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth.

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth.

Journal: Nature metabolism
Published: February 23, 2022

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming.

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming.

Journal: Nature communications
Published: November 19, 2020

Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.

Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.

Journal: Cancer discovery
Published: November 20, 2019

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.

Journal: Nature medicine
Published: April 01, 2016
Showing 1-7 of 7

Last Updated: 09/26/2026